Montag & Associates’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8K | Hold |
542
| – | – | ﹤0.01% | 609 |
|
|
2025
Q1 | $61.9K | Hold |
542
| – | – | ﹤0.01% | 569 |
|
|
2024
Q4 | $27.3K | Hold |
542
| – | – | ﹤0.01% | 686 |
|
|
2024
Q3 | $25.1K | Hold |
542
| – | – | ﹤0.01% | 708 |
|
|
2024
Q2 | $17.6K | Hold |
542
| – | – | ﹤0.01% | 718 |
|
|
2024
Q1 | $13.7K | Hold |
542
| – | – | ﹤0.01% | 734 |
|
|
2023
Q4 | $17.6K | Hold |
542
| – | – | ﹤0.01% | 703 |
|
|
2023
Q3 | $14.8K | Hold |
542
| – | – | ﹤0.01% | 693 |
|
|
2023
Q2 | $12.1K | Hold |
542
| – | – | ﹤0.01% | 723 |
|
|
2023
Q1 | $11.7K | Hold |
542
| – | – | ﹤0.01% | 721 |
|
|
2022
Q4 | $11K | Hold |
542
| – | – | ﹤0.01% | 725 |
|
|
2022
Q3 | $14K | Hold |
542
| – | – | ﹤0.01% | 690 |
|
|
2022
Q2 | $13K | Hold |
542
| – | – | ﹤0.01% | 676 |
|
|
2022
Q1 | $12K | Hold |
542
| – | – | ﹤0.01% | 706 |
|
|
2021
Q4 | $11K | Hold |
542
| – | – | ﹤0.01% | 718 |
|
|
2021
Q3 | $11K | Hold |
542
| – | – | ﹤0.01% | 720 |
|
|
2021
Q2 | $12K | Hold |
542
| – | – | ﹤0.01% | 711 |
|
|
2021
Q1 | $13K | Hold |
542
| – | – | ﹤0.01% | 706 |
|
|
2020
Q4 | $14K | Buy |
+542
| New | +$14K | ﹤0.01% | 671 |
|